SCHEMBL2310441

SCHEMBL2310441

OCCc1cc2cc(CCO)cc3c4cccc5cccc(c(c1)c23)c54

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.39
ALDH1A1 P00352 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
THRB P10828 1/20 0.39
ERBB2 P04626 1/20 0.36
FYN P06241 1/20 0.36
MAOA P21397 1/20 0.36
ACHE P22303 1/20 0.36
AHR P35869 1/20 0.36
KDM4E B2RXH2 2/20 0.34
ALOX5 P09917 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
BACE1 P56817 1/20 0.34
CYP4F2 P78329 3/20 0.34
CYP4A11 Q02928 3/20 0.34
CDK8 P49336 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2311215 0.96 CYP1A2 (0.40) CYP1A2ALDH1A1TDP1HPGDHSD17B10
SCHEMBL2312322 0.94 TDP1 (0.40) CYP1A2ALDH1A1TDP1HPGDHSD17B10
SCHEMBL2309839 0.94 TDP1 (0.40) CYP1A2ALDH1A1TDP1HPGDHSD17B10
SCHEMBL2306854 0.86 TDP1 (0.39) ALDH1A1TDP1KDM4EALOX5GAA
SCHEMBL2313029 0.85 MEN1 (0.38) CYP1A2ALDH1A1TDP1HPGDHSD17B10
SCHEMBL2311140 0.85 CYP1A2 (0.39) CYP1A2ALDH1A1TDP1HPGDHSD17B10
SCHEMBL2306875 0.85 CYP1A2 (0.39) CYP1A2ALDH1A1TDP1HPGDHSD17B10
SCHEMBL2310224 0.84 MEN1 (0.37) CYP1A2TDP1ERBB2FYNMAOA
SCHEMBL2310398 0.84 MEN1 (0.37) CYP1A2TDP1ERBB2FYNMAOA
SCHEMBL2309246 0.82 CYP1A2 (0.40) CYP1A2ALDH1A1TDP1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989517-B2 Actinic ray curable composition, actinic ray curable ink, and image formation process employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-08-02 US disclosed
US-20070123600-A1 ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, AND IMAGE FORMATION PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-31 US disclosed